ACE2, the Counter-Regulatory Renin-Angiotensin System Axis and COVID-19 Severity.
Filippos Triposkiadis,Andrew Xanthopoulos,Grigorios Giamouzis,Konstantinos Dean Boudoulas,Randall C. Starling,John Skoularigis,Harisios Boudoulas,Efstathios K. Iliodromitis +7 more
Reads0
Chats0
TLDR
In this article, the relationship between ACE2 expression and function in the lungs and other organs and COVID-19 severity was discussed and the effect of ACE2 upregulation with renin-angiotensin-aldosterone system inhibitors (RAASi) counterbalances the risks due to counterregulatory RAS axis amplification.Abstract:
Angiotensin (ANG)-converting enzyme (ACE2) is an entry receptor of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes coronavirus disease 2019 (COVID-19). ACE2 also contributes to a deviation of the lung renin-angiotensin system (RAS) towards its counter-regulatory axis, thus transforming harmful ANG II to protective ANG (1-7). Based on this purported ACE2 double function, it has been put forward that the benefit from ACE2 upregulation with renin-angiotensin-aldosterone system inhibitors (RAASi) counterbalances COVID-19 risks due to counter-regulatory RAS axis amplification. In this manuscript we discuss the relationship between ACE2 expression and function in the lungs and other organs and COVID-19 severity. Recent data suggested that the involvement of ACE2 in the lung counter-regulatory RAS axis is limited. In this setting, an augmentation of ACE2 expression and/or a dissociation of ACE2 from the ANG (1-7)/Mas pathways that leaves unopposed the ACE2 function, the SARS-CoV-2 entry receptor, predisposes to more severe disease and it appears to often occur in the relevant risk factors. Further, the effect of RAASi on ACE2 expression and on COVID-19 severity and the overall clinical implications are discussed.read more
Citations
More filters
Journal ArticleDOI
Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets.
Masoumeh Farahani,Zahra Niknam,Leila Mohammadi Amirabad,Nasrin Amiri-Dashatan,Mehdi Koushki,Mohadeseh Nemati,Fahima Danesh Pouya,Mostafa Rezaei-Tavirani,Yousef Rasmi,Lobat Tayebi +9 more
TL;DR: In this article, a review of the possible mechanisms of the host response following SARS-CoV-2 infection and surveyed current research conducted by in-vitro, in vivo and human observations, as well as existing suggestions.
Journal ArticleDOI
Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets
TL;DR: In this paper , a review of the possible mechanisms of the host response following SARS-CoV-2 infection and surveyed current research conducted by in vitro, in vivo and human observations, as well as existing suggestions.
Journal ArticleDOI
A Natural Plant Source-Tea Polyphenols, a Potential Drug for Improving Immunity and Combating Virus
TL;DR: TP can improve the disorder of flora, reduce the occurrence of cytokine storm, improve immunity, and prevent COVID-19 infection, and may be regarded as a potential and valuable source of new antiviral drugs with high efficiency and low toxicity.
Journal ArticleDOI
Anti-human ACE2 antibody neutralizes and inhibits virus production of SARS-CoV-2 variants of concern
A. Chaouat,Ilija Brizić,Paola Kucan Brlic,Nofar Atari,L. Kliker,Orit Alfi,Michal Mandelboim,Dana G. Wolf,Laith Tafish,Inbal Kol,Stipan Jonjić,Ofer Mandelboim +11 more
TL;DR: Wang et al. as mentioned in this paper developed a specific antibody against human ACE2 named hACE2.16, an anti-ACE2 antibody that recognizes and blocks ACE2-RBD binding without affecting ACE2 enzymatic activity.
Journal ArticleDOI
Counter-regulatory renin-angiotensin system in hypertension: Review and update in the era of COVID-19 pandemic
Wolfgang Sipos,Southgate, Jack +1 more
TL;DR: In this article , the authors summarize the latest insights into the complexity and interplay of the counter-regulatory RAS axis in hypertension, highlight the pathophysiological functions of ACE2, a multifunctional molecule linking hypertension and COVID-19, and discuss the function and therapeutic potential of targeting this counterregulatory rAS axis to prevent and treat hypertension in the context of the current COVID19 pandemic.
References
More filters
Journal ArticleDOI
Tobacco Smoking Increases the Lung Gene Expression of ACE2, the Receptor of SARS-CoV-2.
TL;DR: It is imperative to identify potential risk factors, such as cigarette smoking, which is a substantial risk factor for various important bacterial and viral infections, to enable effective prevention and care in the current severe global emergency.
Journal ArticleDOI
Angiotensin-Converting Enzyme II in the Heart and the Kidney
TL;DR: ACE2 not only controls angiotensin II levels but functions as a protease on additional molecular targets that could contribute to the observed in vivo phenotypes of ACE2 mutant mice, suggesting that ACE2 seems to be a molecule that has protective roles in heart and kidney.
Journal ArticleDOI
Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors
Carlos M. Ferrario,Jewell A. Jessup,Patricia E. Gallagher,David B. Averill,K. Bridget Brosnihan,E. Ann Tallant,Ronald D. Smith,Mark C. Chappell +7 more
TL;DR: The data revealed a role for ACE2 in Ang-(1-7) formation from Ang II in the kidney of normotensive rats as primarily reflected by the increased ACE2 activity measured in renal membranes from the kidneys of rats given either lisinopril or losartan.
Journal ArticleDOI
Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts.
Luka Nicin,Wesley Abplanalp,Hannah Mellentin,Badder Kattih,Lukas Tombor,David John,Jan D. Schmitto,Jörg Heineke,Fabian Emrich,Mani Arsalan,Tomas Holubec,Thomas Walther,Andreas M. Zeiher,Stefanie Dimmeler +13 more
TL;DR: This poster presents a poster presented at the 2016 European Conference on Cardiovascular Regeneration and Cardiopulmonary Institute (ECAS) at the University of Heidelberg, Germany, on the topic of regenerative medicine and cardiothoracic surgery.
Journal ArticleDOI
Severe Acute Respiratory Syndrome Coronavirus Infection of Mice Transgenic for the Human Angiotensin-Converting Enzyme 2 Virus Receptor
Chien Te K. Tseng,Cheng Huang,Patrick C. Newman,Nan Wang,Krishna Narayanan,Douglas M. Watts,Shinji Makino,Michelle M. Packard,Sherif R. Zaki,Teh Sheng Chan,Clarence J. Peters +10 more
TL;DR: The severity of the disease that developed in these transgenic mice—AC70 in particular—makes these mouse models valuable not only for evaluating the efficacy of antivirals and vaccines, but also for studying SARS coronavirus pathogenesis.